AzTrials
AzTrials

Diabetic Foot, Mobile Application, Patient EducationNCT04265469

Mobile Application For Educating Diabetics About Foot Care

A study testing Diabetic foot education in people with Diabetic Foot, Mobile Application, Patient Education, run by Istanbul Medeniyet University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose: Our aim was to develop a training program on the mobile application and to assess the effect of this training on the participants' knowledge about foot care, their self-efficacy and their behavior levels. Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
Diabetic foot education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
No sites listed yet
Study dates
10 Feb 2016to 7 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosed as a Type 2 diabetic according to ADA criteria at least six months prior to the study,
  • being 18 years of age and over,
  • being literate and fluent in Turkish,
  • not having an active foot ulcer,
  • owning and being able to operate a smart phone,
  • not having any communication or mental problems,
  • consenting to participating in the research.

Who cannot join

  • Patients with advanced retinopathy and those wishing to withdraw from the research were excluded from the study.

About this study

Official title: The Effect of Mobile Application in Foot Care of Type 2 Diabetes Patients: A Randomized Controlled Study

Purpose: Our aim was to develop a training program on the mobile application and to assess the effect of this training on the participants' knowledge about foot care, their self-efficacy and their behavior levels.

Read the detailed description

The universe of this randomized controlled study consisted of 130 patients who had presented to a training and research hospital in Istanbul. The data were collected during the period March-September 2017 with an Information Form, the Diabetic Foot Knowledge Scale, Diabetic Foot Care Self-efficacy Scale, Foot Self-care Behavior Scale and a Feedback Form on the Mobile Application Training.

Being tested
Diabetic foot education
Keywords
Diabetic foot, mobile application, patient education
Medical subject headings
Diabetic Foot

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diabetic foot educationOther

    Give Diabetic foot education via mobile phone

Study groups in NCT04265469
Study groupRoleWhat they receive
Patients with diabetics get mobile educationExperimentalPatients with diabetics get mobile education
Receives: Other: Diabetic foot education
Patients with diabeticsNo interventionPatients with diabetics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. their self-efficacy

    Diabetic Foot Care Self-efficacy Scale is a scale that determines a diabetic individual's perception of self-efficacy with respect to executing diabetic foot care activities. Responses to this nine-item 10-point Likert-type of questionnaire are assessed on a visual scale that ranges from "I'm absolutely unsure=0" to "I'm very sure=10". The lowest possible score on the scale is 0; the highest is 100.

    Measured: change from baseline self efficiancy at week 4.

  2. Diabetes Foot Knowledge

    Diabetes Foot Knowledge Questionnaire (DFKQ) were developed by Garcia et al. as a 5-item instrument that assesses the level of knowledge patients have about foot care. The questionnaire is evaluated on the basis of the total score. An increase in the score indicates that the diabetic individual has an increased level of knowledge about foot care

    Measured: change from baseline Diabetes Foot Knowledge at week 4.

  3. Foot Self-care Behavior

    Foot Self-care Behavior Scale assesses self-efficacy behavior in the context of foot care. It is a 16-item 5-point Likert-type of scale in which responses are assessed as "I do this: 1=Never, 2=Occasionally, 3=Sometimes, 4=Frequently, 5=Always." The lowest possible score on the scale is 16; the highest is 80

    Measured: change from baseline Foot Self-care Behavior at week 4.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2020
  2. Study start10 Feb 2016
  3. Primary completion7 Feb 2017
  4. Study completion7 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04265469
Sponsor's protocol ID
42432568
Status last verified
Feb 2020
First submitted
7 Feb 2020
Last updated
11 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Diabetic foot education in people with Diabetic Foot, Mobile Application, Patient Education, run by Istanbul Medeniyet University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

their self-efficacy (time frame: change from baseline self efficiancy at week 4.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2020; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in